Tumor immunogenomic signatures improve a prognostic model of melanoma survival
- DOI
- 10.1186/s12967-021-02738-0
- Published
- 2021-02-17
- Container
- Journal of Translational Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12967-021-02738-0,
title = {Tumor immunogenomic signatures improve a prognostic model of melanoma survival},
author = {Leah Morales and Danny Simpson and Robert Ferguson and John Cadley and Eduardo Esteva and Kelsey Monson and Vylyny Chat and Carlos Martinez and Jeffrey Weber and Iman Osman and Tomas Kirchhoff},
year = {2021},
journal = {Journal of Translational Medicine},
doi = {10.1186/s12967-021-02738-0},
url = {https://doi.org/10.1186/s12967-021-02738-0}
}RIS
TY - JOUR TI - Tumor immunogenomic signatures improve a prognostic model of melanoma survival AU - Leah Morales AU - Danny Simpson AU - Robert Ferguson AU - John Cadley AU - Eduardo Esteva AU - Kelsey Monson AU - Vylyny Chat AU - Carlos Martinez AU - Jeffrey Weber AU - Iman Osman AU - Tomas Kirchhoff PY - 2021 JO - Journal of Translational Medicine DO - 10.1186/s12967-021-02738-0 UR - https://doi.org/10.1186/s12967-021-02738-0 ER -
APA
Morales, L., Simpson, D., Ferguson, R., Cadley, J., Esteva, E., Monson, K., Chat, V., Martinez, C., Weber, J., Osman, I., & Kirchhoff, T. (2021). Tumor immunogenomic signatures improve a prognostic model of melanoma survival. Journal of Translational Medicine. https://doi.org/10.1186/s12967-021-02738-0
Source records
- crossref · retrieved 2026-09-27T02:48:42.882Z